AU2018900534A0 - Composition and method - Google Patents

Composition and method

Info

Publication number
AU2018900534A0
AU2018900534A0 AU2018900534A AU2018900534A AU2018900534A0 AU 2018900534 A0 AU2018900534 A0 AU 2018900534A0 AU 2018900534 A AU2018900534 A AU 2018900534A AU 2018900534 A AU2018900534 A AU 2018900534A AU 2018900534 A0 AU2018900534 A0 AU 2018900534A0
Authority
AU
Australia
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018900534A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Haemalogix Pty Ltd
Original Assignee
Haemalogix Pty Ltd
Filing date
Publication date
Application filed by Haemalogix Pty Ltd filed Critical Haemalogix Pty Ltd
Publication of AU2018900534A0 publication Critical patent/AU2018900534A0/en
Priority to SG11202007925SA priority Critical patent/SG11202007925SA/en
Priority to CN201980012636.9A priority patent/CN111918879A/en
Priority to US16/970,991 priority patent/US11447571B2/en
Priority to PCT/AU2019/050137 priority patent/WO2019161443A1/en
Priority to CA3091711A priority patent/CA3091711A1/en
Priority to EP19758107.7A priority patent/EP3755724A4/en
Priority to BR112020017018-6A priority patent/BR112020017018A2/en
Priority to AU2019225446A priority patent/AU2019225446B2/en
Priority to JP2020544005A priority patent/JP7490559B2/en
Priority to KR1020207027033A priority patent/KR20210005553A/en
Priority to AU2021202092A priority patent/AU2021202092A1/en
Priority to US17/819,483 priority patent/US20230174675A1/en
Abandoned legal-status Critical Current

Links

AU2018900534A 2018-02-20 2018-02-20 Composition and method Abandoned AU2018900534A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
KR1020207027033A KR20210005553A (en) 2018-02-20 2019-02-20 Anti-lambda myeloma antigen (LMA) binding protein for treatment of LMA-expressing cancer and autoimmune disorders
CA3091711A CA3091711A1 (en) 2018-02-20 2019-02-20 Anti-lambda myeloma antigen (lma) binding proteins to treat lma-expressing cancer and autoimmune disorders
CN201980012636.9A CN111918879A (en) 2018-02-20 2019-02-20 anti-Lambda Myeloma Antigen (LMA) binding proteins for the treatment of LMA expressing cancers and autoimmune diseases
US16/970,991 US11447571B2 (en) 2018-02-20 2019-02-20 Anti-lambda myeloma antigen (LMA) binding proteins to treat LMA-expressing cancer and autoimmune disorders
PCT/AU2019/050137 WO2019161443A1 (en) 2018-02-20 2019-02-20 Anti-lambda myeloma antigen (lma) binding proteins to treat lma-expressing cancer and autoimmune disorders
SG11202007925SA SG11202007925SA (en) 2018-02-20 2019-02-20 Anti-lambda myeloma antigen (lma) binding proteins to treat lma-expressing cancer and autoimmune disorders
EP19758107.7A EP3755724A4 (en) 2018-02-20 2019-02-20 Anti-lambda myeloma antigen (lma) binding proteins to treat lma-expressing cancer and autoimmune disorders
BR112020017018-6A BR112020017018A2 (en) 2018-02-20 2019-02-20 ANTI-ANTIGEN BINDING PROTEINS OF MYELOMA LAMBDA (AML) FOR THE TREATMENT OF AUTOIMMUNE DISORDERS AND CANCERS EXPRESSING AML
AU2019225446A AU2019225446B2 (en) 2018-02-20 2019-02-20 Anti-lambda myeloma antigen (LMA) binding proteins to treat LMA-expressing cancer and autoimmune disorders
JP2020544005A JP7490559B2 (en) 2018-02-20 2019-02-20 Anti-lambda myeloma antigen (LMA) binding proteins for treating LMA-expressing cancers and autoimmune disorders
AU2021202092A AU2021202092A1 (en) 2018-02-20 2021-04-06 Anti-lambda myeloma antigen (LMA) binding proteins to treat LMA-expressing cancer and autoimmune disorders
US17/819,483 US20230174675A1 (en) 2018-02-20 2022-08-12 Anti-lambda myeloma antrigen (lma) binding proteins to treat lma-expressing cancer and autoimmune disorders

Publications (1)

Publication Number Publication Date
AU2018900534A0 true AU2018900534A0 (en) 2018-03-08

Family

ID=

Similar Documents

Publication Publication Date Title
EP3823673A4 (en) Anti-cd112r compositions and methods
EP3626803A4 (en) Composition and method for producing composition
EP3704227A4 (en) Composition and method
EP3708008A4 (en) Oil-and-fat composition and manufacturing method therefor
GB201905559D0 (en) Composition and method
EP3801552A4 (en) Composition and method for inhalation
EP3733650A4 (en) Method for preparing elagolix intermediate and composition thereof
EP3844500A4 (en) Rp182 compositions and methods
EP3590361A4 (en) Luteolin-containing composition and method for manufacturing same
EP3605589A4 (en) Polishing composition and polishing method
EP3706558A4 (en) Compositions and methods for aquaculturing
EP3808357A4 (en) Composition and uses thereof
GB201909542D0 (en) Composition and method
EP3585511A4 (en) Metal-molybdate and method for making the same
EP3843729A4 (en) Novel compositions and methods
EP3773520A4 (en) Bioxomes particles, redoxomes, method and composition
EP3664604A4 (en) Herbicidal composition and method
EP3685845A4 (en) Composition and method for producing same
EP3559115A4 (en) Composition and method for producing composition
EP3758673A4 (en) Hair-coloring composition and method
EP3590360A4 (en) Lutein-containing composition and method for manufacturing same
GB2579687B (en) Composition and method
EP3917320A4 (en) Bacterialcidal methods and compositions
GB201914777D0 (en) Composition and method
AU2018902779A0 (en) Composition and method